Mount Vernon Associates Inc Pfizer Inc Transaction History

Mount Vernon Associates Inc

$121 Million
Q3 2024

A detailed history of Mount Vernon Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Mount Vernon Associates Inc holds 39,613 shares of PFE stock, worth $995,474. This represents 0.95% of its overall portfolio holdings.

Number of Shares

39,613

Previous 35,663 11.08%

Holding current value

$995,474

Previous $998,000 14.83%

% of portfolio

0.95%

Previous 0.88%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$27.7 - $31.39 $109,415 - $123,990	3,950 Added 11.08%	39,613 $1.15 Million
Q2 2024 Jul 19, 2024	SELL	$25.26 - $29.6 $33,924 - $39,752	-1,343 Reduced 3.63%	35,663 $998,000
Q1 2024 Apr 22, 2024	BUY	$25.89 - $29.73 $31,068 - $35,676	1,200 Added 3.35%	37,006 $1.03 Million
Q4 2023 Jan 26, 2024	SELL	$26.13 - $33.94 $7,185 - $9,333	-275 Reduced 0.76%	35,806 $1.03 Million
Q3 2023 Oct 24, 2023	BUY	$32.09 - $37.51 $6,418 - $7,502	200 Added 0.56%	36,081 $1.2 Million
Q2 2023 Jul 24, 2023	BUY	$36.12 - $41.79 $22,647 - $26,202	627 Added 1.78%	35,881 $1.32 Million
Q1 2023 Apr 20, 2023	SELL	$39.39 - $51.28 $17,725 - $23,076	-450 Reduced 1.26%	35,254 $1.44 Million
Q3 2022 Oct 21, 2022	BUY	$43.76 - $53.42 $7,570 - $9,241	173 Added 0.49%	35,704 $1.56 Million
Q2 2022 Jul 22, 2022	BUY	$46.53 - $55.17 $2,000 - $2,372	43 Added 0.12%	35,531 $1.86 Million
Q1 2022 Apr 25, 2022	BUY	$45.75 - $56.69 $38,887 - $48,186	850 Added 2.45%	35,488 $1.84 Million
Q4 2021 Jan 25, 2022	BUY	$41.32 - $61.25 $4,132 - $6,125	100 Added 0.29%	34,638 $2.05 Million
Q3 2021 Oct 20, 2021	BUY	$39.25 - $50.42 $14,718 - $18,907	375 Added 1.1%	34,538 $1.49 Million
Q2 2021 Jul 28, 2021	BUY	$35.91 - $40.68 $35,910 - $40,680	1,000 Added 3.02%	34,163 $1.34 Million
Q4 2020 Jan 25, 2021	BUY	$33.47 - $42.56 $5,857 - $7,448	175 Added 0.53%	33,163 $1.22 Million
Q3 2020 Oct 23, 2020	BUY	$31.75 - $37.25 $3,175 - $3,725	100 Added 0.3%	32,988 $1.21 Million
Q2 2020 Jul 27, 2020	SELL	$30.12 - $36.54 $30,120 - $36,540	-1,000 Reduced 2.95%	32,888 $1.08 Million
Q1 2020 Apr 23, 2020	BUY	$27.03 - $38.62 $32,436 - $46,344	1,200 Added 3.67%	33,888 $1.11 Million
Q2 2019 Jul 30, 2019	SELL	$36.98 - $41.52 $1.01 Million - $1.13 Million	-27,197 Reduced 45.42%	32,688 $1.42 Million
Q2 2019 Jul 25, 2019	BUY	$36.98 - $41.52 $1 Million - $1.12 Million	27,047 Added 82.36%	59,885 $2.59 Million
Q1 2019 Apr 25, 2019	SELL	$37.5 - $41.2 $18,750 - $20,600	-500 Reduced 1.5%	32,838 $1.4 Million
Q4 2018 Jan 24, 2019	SELL	$38.47 - $43.86 $1,923 - $2,193	-50 Reduced 0.15%	33,338 $1.46 Million
Q3 2018 Oct 22, 2018	SELL	$34.47 - $41.81 $13,788 - $16,724	-400 Reduced 1.18%	33,388 $1.47 Million
Q2 2018 Jul 27, 2018	BUY	$32.98 - $35.16 $9,893 - $10,547	300 Added 0.9%	33,788 $1.23 Million
Q3 2017 Oct 24, 2017	BUY	$31.0 - $34.15 $1.04 Million - $1.14 Million	33,488	33,488 $1.2 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mount Vernon Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mount Vernon Associates Inc with notifications on news.

Account

Mount Vernon Associates Inc Pfizer Inc Transaction History